rAAV.sFlt-1

recombinant adeno-associated virus expressing soluble fms-like tyrosine kinase-1

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rAAV.sFlt-1, covering 2017-09-01 to 2017-09-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration [Phase 1, Phase 2]

See pricing